Mr Taimur T. Shah is a consultant urologist and clinical senior lecturer at Imperial College London (ICL). He has a sub-specialist interest in prostate cancer diagnostics, imaging, robotic surgery, focal therapy (high intensity focused ultrasound and cryotherapy) for prostate cancer and minimally invasive treatments for benign prostatic hyperplasia (BPH). He has published extensively in peer-reviewed journals within these fields and been invited to give presentations nationally and internationally.
Mr Shah qualified from University College London (UCL) where he was also awarded a First-Class Honours degree in molecular medicine. He subsequently completed his urological training in the London Deanery rotating through the Charing Cross Hospital, The Royal Marsden Hospital, Barnet and Chase Farm Hospitals and the Whittington Hospital. He subsequently undertook a uro-oncology fellowship in robotic surgery at Guys and St Thomas' hospital.
He has a PhD from University College London (UCL) into focal therapy for newly diagnosed prostate cancer and cancer that has recurred after previous radiotherapy. He has helped design and deliver multiple clinical trials for primary, metastatic and radio-recurrent prostate cancer and is currently part of the Imperial Prostate (IP) Group at Imperial College London (ICL).
He has been an advocate for collaborative and also trainee led research and previously spent five years as vice chair of the British Urology Researchers in surgical training (BURST) research collaborative.
Raised PSA, investigations for prostate cancer, MRI image-fusion targeted prostate biopsies, robotic radical prostatectomy, focal therapy, high intensity focused ultrasound, cryotherapy, enlarged prostate, benign prostate hyperplasia, Rezum water vapour therapy.
Research & publications
Light A, Ahmed HU, Shah TT, 2022, The unclear role of PET-CT in localized radiorecurrent prostate cancer COMMENT, Nature Reviews Urology, ISSN:1759-4812
Clement KD, Light A, Asif A, et al., 2022, A BURST-BAUS consensus document for best practice in the conduct of scrotal exploration for suspected testicular torsion: the Finding Consensus for Orchidopexy in Torsion (FIX-IT) study, Bju International, ISSN:1464-4096
Gao C, Peters M, Kurver P, et al., 2022, Nomogram predicting the probability of spontaneous stone passage in patients presenting with acute ureteric colic., Bju Int
Khadhouri S, Gallagher KM, MacKenzie KR, et al., 2022, Developing a Diagnostic Multivariable Prediction Model for Urinary Tract Cancer in Patients Referred with Haematuria: Results from the IDENTIFY Collaborative Study., Eur Urol Focus
Shah TT, Kanthabalan A, Otieno M, et al., 2022, Magnetic Resonance Imaging and Targeted Biopsies Compared to Transperineal Mapping Biopsies Before Focal Ablation in Localised and Metastatic Recurrent Prostate Cancer After Radiotherapy, European Urology, Vol:81, ISSN:0302-2838, Pages:598-605
Reddy D, Peters M, Shah TT, van Son M, et al., 2022, Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience., Eur Urol, Vol: 81, Pages: 407-413
Grey ADR, Scott R, Shah B, et al., 2022, Multiparametric ultrasound versus multiparametric MRI to diagnose prostate cancer (CADMUS): a prospective, multicentre, paired-cohort, confirmatory study, LANCET ONCOLOGY, Vol: 23, Pages: 428-438, ISSN: 1470-2045
Shah TT, Cathcart P, 2021, Surgical Volume Is Important for Radical Prostatectomy, but Now We Need to Move Beyond Volume as a Proxy for Quality, EUROPEAN UROLOGY, Vol: 80, Pages: 546-548, ISSN: 0302-2838
Shah TT, Reddy D, Peters M, et al., 2021, Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched study, PROSTATE CANCER AND PROSTATIC DISEASES, Vol: 24, Pages: 567-574, ISSN: 1365-7852